The Manchester Cough in Lung Cancer Scale: The Development and Preliminary Validation of a New Assessment Tool

详细信息    查看全文

• 作者：Alex Molassiotis ; RN ; PhD^a ; ^{alex.molassiotis@manchester.ac.uk} ; Jackie Ellis ; BA (Hons) ; MSc ; PhD^c ; Richard Wagland ; RN ; BSc ; MA ; PhD^d ; Mari Lloyd Williams ; MD ; FRCP ; FRCGP ; MMedSci^c ; Chris D. Bailey ; RN ; BA (Hons) ; PhD^d ; Richard Booton ; MBChB ; MRCP ; PhD^e ; Fiona Blackhall ; FRCP ; PhD^f ; Janelle Yorke ; RN ; PhD^a ; Jaclyn A. Smith ; MBChB ; MRCP ; PhD^b
• 关键词：Cough ; lung cancer ; measurement ; scale ; assessment
• 刊名：Journal of Pain and Symptom Management
• 出版年：2013
• 出版时间：February, 2013
• 年：2013
• 卷：45
• 期：2
• 页码：179-190
• 全文大小：433 K

文摘

Context

Cough is a common distressing symptom in lung cancer patients. Its assessment is hampered by the lack of a validated scale to measure the complex cough experience in this population.

Objectives

To describe the development and preliminary validation of a scale to measure cough in lung cancer patients.

Methods

In the first phase, collection of qualitative data from patient interviews, a review of literature, and identification of noncancer cough scales resulted in the development of a pool of 30 items. This item pool was tested for appropriateness of content and breadth of coverage with 18 patients with lung cancer and 25 health care professionals. The second phase was the operationalization/phrasing of items. The final phase was the scale's field testing with 139 patients, 49 of whom repeated the assessment after one week.

Results

The first phase led to the deletion of several items and the addition of four, resulting in a final scale for field testing of 21 items. In the field testing, the scale was decreased to 10 items, eliminating items on psychometric grounds. The final scale's Cronbach alpha (internal consistency) was 0.86, item to total correlations ranged from 0.40 to 0.76, and test-retest reliability was high (intraclass correlation = 0.83).

Conclusion

We have developed a promising tool to assess cough in lung cancer, but this needs validation, and future studies should determine whether this is a sensitive and responsive tool. A fully validated tool can be used in the clinical assessment of cough in cancer patients, and as a unidimensional impact scale in the measurement of cough as an outcome in intervention studies.